RECURSION PHARMACEUTICALS, INC. — Form D/A

RECURSION PHARMACEUTICALS, INC. of SALT LAKE CITY, UT, a company, filed a Form D amendment with the SEC on 2020-11-12. The offering totals $245.9M, of which $245.9M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2020-11-12
• Form: D/A
• Accession: 0001601830-20-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $245.9M
• Amount sold: $245.9M
• Investors: 49
• Date of first sale: 2020-09-01
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-375551

Issuer

• Name: RECURSION PHARMACEUTICALS, INC.
• CIK: 0001601830
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2013
• Address: 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
• Phone: (385) 269-0203

Officers, directors & promoters (33)

Showing 25 of 33 people.

Other filings by this issuer (11)

More

• CIK 1601830 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search